title: Persistence And Adherence With Mirabegron, A New Beta-3 Receptor Agonist, Versus Antimuscarinics In Overactive Bladder: Early Experience In Canada.
authors.affiliation: University of Alberta, Edmonton, AB, Canada.
authors.forename: A
authors.initials: A
authors.lastname: Wagg
authors.affiliation: Astellas Scientific and Medical Affairs, Inc., Northbrook, IL, USA.
authors.forename: B
authors.initials: B
authors.lastname: Franks
authors.affiliation: Astellas Pharma Canada, Inc, Markham, ON, Canada.
authors.forename: B
authors.initials: B
authors.lastname: Ramos
authors.affiliation: Astellas Scientific and Medical Affairs, Inc., Northbrook, IL, USA.
authors.forename: T
authors.initials: T
authors.lastname: Berner